Cart
sales@molnova.com
Ozagrel hydrochloride
CAS No. 78712-43-3
Ozagrel hydrochloride( —— )
Catalog No. M15964 CAS No. 78712-43-3
Ozagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 25MG | 67 | In Stock |
|
| 50MG | 106 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOzagrel hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionOzagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
-
DescriptionOzagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThromboxane A2 synthetase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number78712-43-3
-
Formula Weight264.71
-
Molecular FormulaC13H12N2O2·HCl
-
Purity>98% (HPLC)
-
SolubilityEthanol: 6 mg/mL (22.66 mM); Water: 53 mg/mL (200.21 mM); DMSO: 53 mg/mL (200.21 mM)
-
SMILESC1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.
molnova catalog
related products
-
AZD-0837
AZD-0837 is a novel oral anticoagulant that after bioconversion to its active form is a potent and reversible thrombin inhibitor.
-
Bivalirudin
Bivalirudin is a reversible inhibitor of α- and ζ-thrombin (Kis = 2.56 and 1.84 nM respectively) enzymes that exhibit high fibrinogen-clotting activities.
-
Melagatran
Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
